Search

Your search keyword '"Garderet, L."' showing total 452 results

Search Constraints

Start Over You searched for: Author "Garderet, L." Remove constraint Author: "Garderet, L."
452 results on '"Garderet, L."'

Search Results

1. Second primary malignancies in multiple myeloma: an overview and IMWG consensus

2. Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

4. Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

5. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

6. 32nd International Austrian Winter Symposium: Zell am See, the Netherlands. 20-23 January 2016

8. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

12. Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

13. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

16. Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

17. Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature

18. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

22. Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

26. REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA: A COMPARISON OF TANDEM AUTO-ALLOGRAFT TO EARLY REDUCED INTENSITY ALLOGRAFT AS UPFRONT TRANSPLANT: AN EBMT ANALYSIS ON BEHALF OF THE PLASMA CELL DISORDERS: PH-O144

27. HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) INDUCES DURABLE REMISSIONS IN PATIENTS WITH POEMS SYNDROME: A RETROSPECTIVE STUDY OF THE PLASMA CELL DISORDERS SUBCOMMITTEE OF THE CHRONIC MALIGNANCY WORKING PARTY OF THE EBMT: PH-O134

28. Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

29. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

31. Prophylaxis and treatment of graft-versus-host disease: EBMT - ELN working group recommendations for a standardized practice: 296

33. Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in multiple myeloma - update of the EBMT-NMAM2000 study at 96 months median follow-up: 197

34. Higher probability of survival in complete remission following tandem autologous/reduced-intensity allogeneic transplantation compared to autologous transplantation alone in the NMAM2000 multiple myeloma trial as estimated by multistate models: O158

40. Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: 0117

41. Corrigendum: Second primary malignancies in multiple myeloma: an overview and IMWG consensus

42. Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT: 221

45. Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone to treat multiple myeloma patients progressing or relapsing after autologous transplantation: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT

Catalog

Books, media, physical & digital resources